Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06693960
EARLY_PHASE1
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
Sponsor: Washington State University
View on ClinicalTrials.gov
Summary
The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2024-09-26
Completion Date
2025-12-31
Last Updated
2024-11-26
Healthy Volunteers
Yes
Conditions
Interventions
DIETARY_SUPPLEMENT
Oregano
Oil of oregano administered as a softgel (180 mg).
DRUG
Drug cocktail
Oral drug cocktail consisting of caffeine (100 mg), dextromethorphan (30 mg), losartan (25 mg), midazolam syrup (2 mg), and omeprazole (20 mg).
Locations (1)
Washington State University College of Pharmacy and Pharmaceutical Sciences
Spokane, Washington, United States